CAS 1240-04-6|Estrone sulfate potassium
| Common Name | Estrone sulfate potassium | ||
|---|---|---|---|
| CAS Number | 1240-04-6 | Molecular Weight | 389.52800 |
| Density | / | Boiling Point | / |
| Molecular Formula | C18H21KO5S | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | / |
| Symbol | GHS07, GHS08 | Signal Word | Warning |
Names
| Name | Estrone 3-sulfate potassium salt |
|---|---|
| Synonym | More Synonyms |
Estrone sulfate potassium BiologicalActivity
| Description | Estrone sulfate potassium is a natural endogenous steroid and is an estrogen ester and conjugate[1]. |
|---|---|
| Related Catalog | Research Areas >>Others |
| References | [1]. O'Neil MM, et al. Differential Regulation of Gonadotropins in Response to Continuous Infusion of Native Gonadotropin-Releasing Hormone in the Winter Anovulatory Mare and Effects of Treatment With Estradiol-17β. J Equine Vet Sci. 2019 Apr;75:93-103. |
Chemical & Physical Properties
| Molecular Formula | C18H21KO5S |
|---|---|
| Molecular Weight | 389.52800 |
| Exact Mass | 389.08300 |
| PSA | 89.05000 |
| LogP | 4.37420 |
| Appearance of Characters | off-white to light tan |
| InChIKey | CUQHOFAEIPGLBH-ZFINNJDLSA-N |
| SMILES | CC12CCC3c4ccc(OS(=O)(=O)O)cc4CCC3C1CCC2=O.[K+] |
| Storage condition | −20°C |
Safety Information
| Symbol | GHS07, GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319-H335-H361 |
| Precautionary Statements | P261-P281-P305 + P351 + P338 |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
Articles31
More Articles| Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J. Pharm. Sci. 102(1) , 280-8, (2013) We aimed to explore the major active components in grapefruit juice (GFJ), orange juice (OJ), and apple juice (AJ) that are responsible for OATP2B1-mediated drug interactions, by means of in vitro stu... | |
| Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Eur. J. Pharm. Sci. 47(1) , 244-55, (2012) To support drug development, the drug-drug interaction potential (DDI) of an investigational drug (AZX) was assessed against the probe estradiol 17β-glucuronide as well as against simvastatin acid, at... | |
| Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors. Eur. J. Cancer 50(6) , 1055-64, (2014) Recent data have raised concern about the clinical efficacy of aromatase inhibitors in overweight and/or obese breast cancer patients. We report in vivo aromatase inhibition and plasma and tissue oest... |
Synonyms
| potassium,[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate |
